Resolve Biosciences Launches New Era in Single-Cell Spatial Analysis
December 9, 2020 Company announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular Cartography TM platform MONHEIM AM RHEIN, Germany – Dec. 10, 2020 – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack as Chief Executive Officer. The company's Molecular Cartography platform is a groundbreaking multi-analyte and highly multiplex spatial analysis technol...
Source: bio-itworld.com